FLUOROQUINOLONE-PHENOTHIAZINE HYBRIDS: A NOVEL APPROACH TO ADDRESS THE CHALLENGE OF ANTIMICROBIAL RESISTANCE

Antimicrobial resistance (AMR) is a major threat to global health, posing a serious challenge for treating bacterial infections[1]. One of the mechanisms that may be behind AMR is the increased efflux of antibiotics from bacteria by specialized membrane transporters[2] . Thus, targeting efflux pumps is a promising approach to combat AMR and restore the effectiveness of antibiotics[3] . In turn, the hybridization of antibiotics with efflux pump inhibitors could lead to improved antimicrobial activity and increased efficacy against drug-resistant bacteria. Taking this into account, in this study, we hybridized two fluoroquinolones, ciprofloxacin or norfloxacin, with phenothiazines, a class of compounds with known efflux pump inhibitory activity, to develop novel molecules with dual action[4] . The hybrid molecules were synthesized using nucleophilic substitution reactions and were converted to maleate salts to improve their water-solubility. The antimicrobial activity of fluoroquinolones and their hybrids was evaluated, focusing on minimum inhibitory concentration, time-kill curves, post-antibiotic effects, mutation frequency, efflux pump inhibitory activity, and anti-biofilm activity. Six of the eight synthesized hybrids were more effective at killing bacteria and inhibiting biofilm formation than the reference fluoroquinolone. Moreover, these new compounds reduced mutation frequency compared to the reference fluoroquinolone and improved ethidium bromide accumulation, demonstrating that the hybrid compounds may inhibit efflux pumps. These results may contribute to ongoing efforts to develop innovative strategies to combat bacterial infections and provide potential alternatives in the fight against antimicrobial resistance

Funding: João L. Serrano acknowledges a doctoral fellowship grant from the FCT (SFRH/BD/148028/2019). This research was funded by the scope of the CICS-UBI projects UIDB/00709/2020 and UIDP/00709/2020, financed by national funds through the Portuguese Foundation for Science and Technology/MCTES. The NMR spectrometers are part of the Portuguese NMR Network (PTNMR) and are partially supported by the Infrastructure Project No. 022161 (co-financed by FEDER through COMPETE 2020, POCI and PORL and FCT through PIDDAC).

Acknowledgments: Staphylococcus aureus SA1199 and SA1199A were kindly provided by Professor Dr. Lorena Tuchscherr de Hauschopp (Jena University Hospital-Germany).

Conflicts of Interest: The authors declare no conflict of interest.

References

1. EClinicalMedicine Antimicrobial resistance: a top ten global public health threat. eClinicalMedicine 2021, 41, 101221, doi:10.1016/j.eclinm.2021.101221.
2. Barnabas, V.; Kashyap, A.; Raja, R.; Newar, K.; Rai, D.; Dixit, N.M.; Mehra, S. The Extent of Antimicrobial Resistance Due to Efflux Pump Regulation. ACS Infect. Dis. 2022, 8, 2374–2388, doi:10.1021/acsinfecdis.2c00460.
3. Sharma, A.; Gupta, V.K.; Pathania, R. Efflux pump inhibitors for bacterial pathogens: From bench to bedside. Indian J. Med. Res. 2019, 149, 129–145, doi:10.4103/ijmr.IJMR_2079_17.
4. Grimsey, E.M.; Piddock, L.J. V Do Phenothiazines Possess Antimicrobial and Efflux Inhibitory Properties? FEMS Microbiol. Rev. 2019, 43, 577–590, doi:10.1093/femsre/fuz017.